Abstract
Already in the 19th century, it was accepted that tissues display clot-promoting activity. The awareness that a single protein was accountable for this pro-coagulant effect led to the detection of tissue factor (tissue factor), but for many years it was thought that tissue factor activity was restricted to the activation of an auxiliary pathway that had little biological significance. Today tissue factor is recognised to be the primary biological initiator of the coagulation cascade. In silico studies have highlighted the high degree of structural similarity of tissue factor with the super family of interferon receptors. The cytokine class II receptor family has probably evolved from an ancient gene coding for a pre-eukaryotic extracellular protein. Tissue factor evolved from this protein and matching sequences are found in invertebrates, especially insects. From tissue factor, the other receptors evolved. Strikingly, the common evolutionary origin of tissue factor and cytokine receptors is reflected in identical signalling. The evolutionary origin of tissue factor is the subject of the present review.
Keywords: Chordates, cytokines receptors, tissue factor, prokariotic secretion system 2
Current Genomics
Title: Functional Evolution of Tissue Factor, the Archetype of the Cytokine Receptor Family
Volume: 6 Issue: 6
Author(s): C. A. Spek, M. V. Zoelen, S. H. Diks and M. P. Peppelenbosch
Affiliation:
Keywords: Chordates, cytokines receptors, tissue factor, prokariotic secretion system 2
Abstract: Already in the 19th century, it was accepted that tissues display clot-promoting activity. The awareness that a single protein was accountable for this pro-coagulant effect led to the detection of tissue factor (tissue factor), but for many years it was thought that tissue factor activity was restricted to the activation of an auxiliary pathway that had little biological significance. Today tissue factor is recognised to be the primary biological initiator of the coagulation cascade. In silico studies have highlighted the high degree of structural similarity of tissue factor with the super family of interferon receptors. The cytokine class II receptor family has probably evolved from an ancient gene coding for a pre-eukaryotic extracellular protein. Tissue factor evolved from this protein and matching sequences are found in invertebrates, especially insects. From tissue factor, the other receptors evolved. Strikingly, the common evolutionary origin of tissue factor and cytokine receptors is reflected in identical signalling. The evolutionary origin of tissue factor is the subject of the present review.
Export Options
About this article
Cite this article as:
Spek A. C., Zoelen V. M., Diks H. S. and Peppelenbosch P. M., Functional Evolution of Tissue Factor, the Archetype of the Cytokine Receptor Family, Current Genomics 2005; 6 (6) . https://dx.doi.org/10.2174/138920205774483025
DOI https://dx.doi.org/10.2174/138920205774483025 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Screening of Photosynthetic Pigments for Herbicidal Activity with a New Computational Molecular Approach
Combinatorial Chemistry & High Throughput Screening The Immunomodulatory Effects of Physical Activity
Current Pharmaceutical Design Therapeutic Approaches for Lysosomal Storage Diseases: A Patent Update
Recent Patents on CNS Drug Discovery (Discontinued) Recent Patents on Oral Vaccine Design
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Hydrogels in Tissue Engineering: Scope and Applications
Current Pharmaceutical Biotechnology Polymeric Carrier Systems for siRNA Delivery
Current Topics in Medicinal Chemistry Peroxisome Proliferator-Activated Receptor-γ and Its Ligands in the Treatment of Tumors in the Nervous System
Current Stem Cell Research & Therapy Development of Hedgehog Pathway Inhibitors (HPI) in Treatment of Cancer
Current Chemical Biology Immune Responses to Gene Product of Inducible Promoters
Current Gene Therapy Neuroprotective Therapies for Alzheimers Disease
Current Pharmaceutical Design The Pattern of Abbreviation Use in Prescriptions: A Way Forward in Eliminating Error-Prone Abbreviations and Standardisation of Prescriptions
Current Drug Safety Structures of TGF-β Receptor Complexes: Implications for Function and Therapeutic Intervention Using Ligand Traps
Current Pharmaceutical Biotechnology Current and Future Prospective of a Versatile Moiety: Imidazole
Current Drug Targets Using Microgravity for Defining Novel Anti-Atherosclerotic Therapy
Current Genomics Pituitary Stem Cells Drop Their Mask
Current Stem Cell Research & Therapy A General Approach on Surfactants Use and Properties in Drug Delivery Systems
Current Pharmaceutical Design A Review on the Nutritional Aspects of Wild Edible Plants
Current Traditional Medicine A Walk in Nature: Sesquiterpene Lactones as Multi-Target Agents Involved in Inflammatory Pathways
Current Medicinal Chemistry A Progressive Review of V600E-B-RAF-Dependent Melanoma and Drugs Inhibiting It
Mini-Reviews in Medicinal Chemistry Development of Bromfenac Sodium Loaded Pluronic Nanomicelles: Characterization and Corneal Permeation Study
Recent Advances in Drug Delivery and Formulation